Federal
End Taxpayer Funding of Gender Experimentation Act of 2021
Source: Congress.gov ·
2,306 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
117TH CONGRESS
1ST SESSION
S. 777
To prohibit taxpayer-funded gender reassignment medical interventions, and
for other purposes.
IN THE SENATE OF THE UNITED STATES
MARCH 16, 2021
Mr. MARSHALL (for himself, Mr. BRAUN, Mr. COTTON, Mrs. BLACKBURN, Mr.
LEE, and Mrs. HYDE-SMITH) introduced the following bill; which was
read twice and referred to the Committee on Finance
A BILL
To prohibit taxpayer-funded gender reassignment medical
interventions, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
3
(a) SHORT TITLE.—This Act may be cited as the
4
‘‘End Taxpayer Funding of Gender Experimentation Act
5
of 2021’’.
6
(b) TABLE OF CONTENTS.—The table of contents of
7
this Act is as follows:
8
Sec. 1. Short title; table of contents.
TITLE I—PROHIBITING FEDERALLY FUNDED GENDER
REASSIGNMENT MEDICAL INTERVENTIONS
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6211
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
2
•S 777 IS
Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interven-
tions.
Sec. 102. Amendment to table of chapters.
TITLE II—APPLICATION UNDER THE AFFORDABLE CARE ACT
Sec. 201. Clarifying application of prohibition to premium credits and cost-
sharing reductions under ACA.
TITLE I—PROHIBITING FEDER-
1
ALLY FUNDED GENDER REAS-
2
SIGNMENT MEDICAL INTER-
3
VENTIONS
4
SEC. 101. PROHIBITING TAXPAYER-FUNDED GENDER REAS-
5
SIGNMENT MEDICAL INTERVENTIONS.
6
Title 1, United States Code, is amended by adding
7
at the end the following new chapter:
8
‘‘CHAPTER
4—PROHIBITING
TAXPAYER-
9
FUNDED
GENDER
REASSIGNMENT
10
MEDICAL INTERVENTIONS
11
‘‘301. Prohibition on funding for gender reassignment medical interventions.
‘‘302. Prohibition on funding for health benefits plans that cover gender reas-
signment medical interventions.
‘‘303. Limitation on Federal facilities and employees.
‘‘304. Construction relating to separate coverage.
‘‘305. Construction relating to the use of non-Federal funds for health coverage.
‘‘306. Construction relating to complications arising from gender reassignment
medical interventions.
‘‘307. Treatment of individuals born with medically verifiable disorder of sex de-
velopment.
‘‘308. Gender reassignment medical intervention defined.
‘‘§ 301. Prohibition on funding for gender reassign-
12
ment medical interventions
13
‘‘No funds authorized or appropriated by Federal
14
law, and none of the funds in any trust fund to which
15
funds are authorized or appropriated by Federal law, shall
16
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
3
•S 777 IS
be expended for any gender reassignment medical inter-
1
vention.
2
‘‘§ 302. Prohibition on funding for health benefits
3
plans that cover gender reassignment
4
medical interventions
5
‘‘No funds authorized or appropriated by Federal
6
law, and none of the funds in any trust fund to which
7
funds are authorized or appropriated by Federal law, shall
8
be expended for health benefits coverage that includes cov-
9
erage of gender reassignment medical interventions.
10
‘‘§ 303. Limitation on Federal facilities and employees
11
‘‘No health care service furnished—
12
‘‘(1) by or in a health care facility owned or op-
13
erated by the Federal Government; or
14
‘‘(2) by any physician or other individual em-
15
ployed by the Federal Government to provide health
16
care services within the scope of the physician’s or
17
individual’s employment,
18
may include gender reassignment medical interventions.
19
‘‘§ 304. Construction relating to separate coverage
20
‘‘Nothing in this chapter shall be construed as pro-
21
hibiting any individual, entity, or State or locality from
22
purchasing separate coverage for gender reassignment
23
medical interventions or health benefits coverage that in-
24
cludes gender reassignment medical interventions so long
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
4
•S 777 IS
as such coverage is paid for entirely using only funds not
1
authorized or appropriated by Federal law and such cov-
2
erage shall not be purchased using matching funds re-
3
quired for a federally subsidized program, including a
4
State’s or locality’s contribution of Medicaid matching
5
funds.
6
‘‘§ 305. Construction relating to the use of non-Fed-
7
eral funds for health coverage
8
‘‘Nothing in this chapter shall be construed as re-
9
stricting the ability of any non-Federal health benefits cov-
10
erage provider from offering coverage for gender reassign-
11
ment medical interventions, or the ability of a State or
12
locality to contract separately with such a provider for
13
such coverage, so long as only funds not authorized or ap-
14
propriated by Federal law are used and such coverage
15
shall not be purchased using matching funds required for
16
a federally subsidized program, including a State’s or lo-
17
cality’s contribution of Medicaid matching funds.
18
‘‘§ 306. Construction relating to complications arising
19
from gender reassignment medical inter-
20
ventions
21
‘‘Nothing in this chapter shall be construed to apply
22
to the treatment of any infection, injury, disease, or dis-
23
order that has been caused by or exacerbated by the per-
24
formance of a gender reassignment medical intervention.
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
5
•S 777 IS
This rule of construction shall be applicable without re-
1
gard to whether the gender reassignment medical inter-
2
vention was performed in accord with Federal or State
3
law, and without regard to whether funding for the gender
4
reassignment medical intervention is permissible under
5
section 307.
6
‘‘§ 307. Treatment of individuals born with medically
7
verifiable disorder of sex development
8
‘‘The limitations established in sections 301, 302,
9
and 303 shall not apply with respect to the following indi-
10
viduals:
11
‘‘(1) An individual with external biological sex
12
characteristics that are irresolvably ambiguous, such
13
as those born with 46 XX chromosomes with
14
virilization,
46
XY
chromosomes
with
15
undervirilization, or having both ovarian and testic-
16
ular tissue.
17
‘‘(2) An individual with respect to whom a phy-
18
sician has determined through genetic or biochemical
19
testing that the individual does not have normal sex
20
chromosome structure, sex steroid hormone produc-
21
tion, or sex steroid hormone action for a biological
22
male or female.
23
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
6
•S 777 IS
‘‘§ 308. Gender reassignment medical intervention de-
1
fined
2
‘‘For purposes of this chapter, the term ‘gender reas-
3
signment medical intervention’ means—
4
‘‘(1) performing a surgery that sterilizes an in-
5
dividual,
including
castration,
vasectomy,
6
hysterectomy,
oophorectomy,
metoidioplasty,
7
penectomy, phalloplasty, and vaginoplasty, to change
8
the body of such individual to correspond to a sex
9
that is discordant with biological sex;
10
‘‘(2) performing a mastectomy on an individual
11
for the purpose described in paragraph (1); and
12
‘‘(3) administering or supplying to an individual
13
medications for the purpose described in paragraph
14
(1), including—
15
‘‘(A) GnRH agonists or other puberty-
16
blocking drugs to stop or delay normal puberty;
17
‘‘(B) testosterone or other androgens to bi-
18
ological
females
at
doses
that
are
19
supraphysiologic to the female sex; and
20
‘‘(C) estrogen to biological males at doses
21
that are supraphysiologic to the male sex.’’.
22
SEC. 102. AMENDMENT TO TABLE OF CHAPTERS.
23
The table of chapters for title 1, United States Code,
24
is amended by adding at the end the following new item:
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
7
•S 777 IS
‘‘4. Prohibiting taxpayer-funded gender reassignment
medical interventions ..........................................
301’’.
TITLE II—APPLICATION UNDER
1
THE AFFORDABLE CARE ACT
2
SEC. 201. CLARIFYING APPLICATION OF PROHIBITION TO
3
PREMIUM CREDITS AND COST-SHARING RE-
4
DUCTIONS UNDER ACA.
5
(a) IN GENERAL.—
6
(1) DISALLOWANCE OF REFUNDABLE CREDIT
7
AND
COST-SHARING
REDUCTIONS
FOR
COVERAGE
8
UNDER QUALIFIED HEALTH PLAN WHICH PROVIDES
9
COVERAGE
FOR
GENDER
REASSIGNMENT
MEDICAL
10
INTERVENTIONS.—
11
(A) IN
GENERAL.—Subparagraph (A) of
12
section 36B(c)(3) of the Internal Revenue Code
13
of 1986 is amended by inserting before the pe-
14
riod at the end the following: ‘‘or any health
15
plan that includes coverage for gender reassign-
16
ment medical interventions (other than any
17
gender reassignment medical intervention or
18
treatment described in section 306 or 307 of
19
title 1, United States Code)’’.
20
(B) OPTION TO PURCHASE OR OFFER SEP-
21
ARATE COVERAGE OR PLAN.—Paragraph (3) of
22
section 36B(c) of such Code is amended by
23
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
8
•S 777 IS
adding at the end the following new subpara-
1
graph:
2
‘‘(C) SEPARATE COVERAGE OR PLAN FOR
3
GENDER
REASSIGNMENT
MEDICAL
INTERVEN-
4
TIONS ALLOWED.—
5
‘‘(i) OPTION TO PURCHASE SEPARATE
6
COVERAGE OR PLAN.—Nothing in subpara-
7
graph (A) shall be construed as prohibiting
8
any individual from purchasing separate
9
coverage for gender reassignment medical
10
interventions described in such subpara-
11
graph, or a health plan that includes such
12
gender reassignment medical interventions,
13
so long as no credit is allowed under this
14
section with respect to the premiums for
15
such coverage or plan.
16
‘‘(ii) OPTION TO OFFER COVERAGE OR
17
PLAN.—Nothing in subparagraph (A) shall
18
restrict any non-Federal health insurance
19
issuer offering a health plan from offering
20
separate coverage for gender reassignment
21
medical interventions described in such
22
subparagraph, or a plan that includes such
23
gender reassignment medical interventions,
24
so long as premiums for such separate cov-
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
9
•S 777 IS
erage or plan are not paid for with any
1
amount attributable to the credit allowed
2
under this section (or the amount of any
3
advance payment of the credit under sec-
4
tion 1412 of the Patient Protection and
5
Affordable Care Act).’’.
6
(2) DISALLOWANCE
OF
SMALL
EMPLOYER
7
HEALTH
INSURANCE
EXPENSE
CREDIT
FOR
PLAN
8
WHICH
INCLUDES
COVERAGE
FOR
GENDER
REAS-
9
SIGNMENT
MEDICAL
INTERVENTIONS.—Subsection
10
(h) of section 45R of the Internal Revenue Code of
11
1986 is amended—
12
(A) by striking ‘‘Any term’’ and inserting
13
the following:
14
‘‘(1) IN GENERAL.—Any term’’; and
15
(B) by adding at the end the following new
16
paragraph:
17
‘‘(2) EXCLUSION OF HEALTH PLANS INCLUDING
18
COVERAGE
FOR
GENDER
REASSIGNMENT
MEDICAL
19
INTERVENTIONS.—
20
‘‘(A) IN
GENERAL.—The term ‘qualified
21
health plan’ does not include any health plan
22
that includes coverage for gender reassignment
23
medical interventions (other than any gender
24
reassignment medical intervention or treatment
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
10
•S 777 IS
described in section 306 or 307 of title 1,
1
United States Code).
2
‘‘(B) SEPARATE COVERAGE OR PLAN FOR
3
GENDER
REASSIGNMENT
MEDICAL
INTERVEN-
4
TIONS ALLOWED.—
5
‘‘(i) OPTION TO PURCHASE SEPARATE
6
COVERAGE OR PLAN.—Nothing in subpara-
7
graph (A) shall be construed as prohibiting
8
any employer from purchasing for its em-
9
ployees separate coverage for gender reas-
10
signment medical interventions described
11
in such subparagraph, or a health plan
12
that includes such gender reassignment
13
medical interventions, so long as no credit
14
is allowed under this section with respect
15
to the employer contributions for such cov-
16
erage or plan.
17
‘‘(ii) OPTION TO OFFER COVERAGE OR
18
PLAN.—Nothing in subparagraph (A) shall
19
restrict any non-Federal health insurance
20
issuer offering a health plan from offering
21
separate coverage for gender reassignment
22
medical interventions described in such
23
subparagraph, or a plan that includes such
24
gender reassignment medical interventions,
25
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
11
•S 777 IS
so long as such separate coverage or plan
1
is not paid for with any employer contribu-
2
tion eligible for the credit allowed under
3
this section.’’.
4
(b) APPLICATION TO MULTI-STATE PLANS.—Section
5
1334(a) of Public Law 111–148 (42 U.S.C. 18054(a)) is
6
amended by adding at the end the following new para-
7
graph:
8
‘‘(8) COVERAGE
CONSISTENT
WITH
FEDERAL
9
POLICY REGARDING GENDER REASSIGNMENT MED-
10
ICAL
INTERVENTIONS.—In entering into contracts
11
under this subsection, the Director shall ensure that
12
no multi-State qualified health plan offered in an
13
Exchange provides health benefits coverage for
14
which the expenditure of Federal funds is prohibited
15
under chapter 4 of title 1, United States Code.’’.
16
(c) EFFECTIVE DATE.—The amendments made by
17
subsection (a) shall apply to taxable years ending after
18
the date that is one year after the date of enactment of
19
this Act, but only with respect to plan years beginning
20
after such date, and the amendment made by subsection
21
(b) shall apply to plan years beginning after such date.
22
Æ
VerDate Sep 11 2014
18:17 Apr 09, 2021
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6301
E:\BILLS\S777.IS
S777
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.